Drug Development

Listings
  • Anti-161P2F10B (clone H16-7.8)-Mc-MMAF ADC

    Anti-161P2F10B (clone H16-7.8)-Mc-MMAF ADC

    Drug Development Shirley (New York) November 11, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti- 161P2F10B monoclonal antibody (clone H16-7.8 ) conjugated via a Mc linker to MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosi...

  • Anti-DLL3 (clone SC16.56)-PBD dimers ADC

    Anti-DLL3 (clone SC16.56)-PBD dimers ADC

    Drug Development Shirley (New York) November 29, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-DLL3 monoclonal antibody (clone SC16.56) conjugated via a linker to PBD dimers. The PBD dimers is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocyto...

  • Human anti-CMV T cell receptor (Cysteine-modified TCR), pMP71

    Human anti-CMV T cell receptor (Cysteine-modified TCR), pMP71

    Drug Development Shirley (New York) February 8, 2018 1.00 Dollar US$

    The vector of anti-CMV T cell receptor (TCR) is constructed for the engineering of T cell to target CMV. The T cells are genetically modified through transduction with a retroviral vector expressing CMV-specific T cell receptor. And the vector produc...

  • Anti-191P4D12 (clone Ha22-2(2,4)6.1)-VC-MMAE ADC

    Anti-191P4D12 (clone Ha22-2(2,4)6.1)-VC-MMAE ADC

    Drug Development Shirley (New York) November 11, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-191P4D12 monoclonal antibody (clone Ha22-2(2,4)6.1)) conjugated via a VC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endoc...

  • Anti-DLL3 (clone SC16.13)-PBD dimers ADC

    Anti-DLL3 (clone SC16.13)-PBD dimers ADC

    Drug Development Shirley (New York) November 29, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-DLL3 monoclonal antibody (clone SC16.13) conjugated via a linker to PBD dimers. The PBD dimers is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocyto...

  • Human anti-CMV T cell receptor (Cysteine-modified TCR), pMP71

    Human anti-CMV T cell receptor (Cysteine-modified TCR), pMP71

    Drug Development Shirley (New York) February 8, 2018 1.00 Dollar US$

    The vector of anti-CMV T cell receptor (TCR) is constructed for the engineering of T cell to target CMV. The T cells are genetically modified through transduction with a retroviral vector expressing CMV-specific T cell receptor. And the vector produc...

  • Anti-24P4C12 (clone Ha5-l(5)2.1)-VC-MMAE ADC

    Anti-24P4C12 (clone Ha5-l(5)2.1)-VC-MMAE ADC

    Drug Development Shirley (New York) November 11, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-24P4C12 monoclonal antibody (clone Ha5-l(5)2.1)) conjugated via a VC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytos...

  • Anti-DLL3-PBD ADC

    Anti-DLL3-PBD ADC

    Drug Development Shirley (New York) November 29, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-DLL3 monoclonal antibody conjugated via a linker to PDB. The PDB is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, PDB bind...

  • Human anti-CMV T cell receptor (Cysteine-modified TCR), pMP71

    Human anti-CMV T cell receptor (Cysteine-modified TCR), pMP71

    Drug Development Shirley (New York) February 8, 2018 1.00 Dollar US$

    The vector of anti-CMV T cell receptor (TCR) is constructed for the engineering of T cell to target CMV. The T cells are genetically modified through transduction with a retroviral vector expressing CMV-specific T cell receptor. And the vector produc...

  • Anti-24P4C12 proteins (clone (Ha5)-1(5)2.1)-VC-MMAE ADC

    Anti-24P4C12 proteins (clone (Ha5)-1(5)2.1)-VC-MMAE ADC

    Drug Development Shirley (New York) November 11, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-24P4C12 proteins monoclonal antibody (clone (Ha5)-1(5)2.1) conjugated via a VC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated...

  • Anti-DLL3-PBD ADC

    Anti-DLL3-PBD ADC

    Drug Development Shirley (New York) November 29, 2017 1.00 Dollar US$

    This ADC product is comprised of an anti-DLL3 monoclonal antibody conjugated via a linker to PDB. The PDB is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, PDB bind...

  • Human anti-HCV T cell receptor, pLXSN

    Human anti-HCV T cell receptor, pLXSN

    Drug Development Shirley (New York) February 8, 2018 1.00 Dollar US$

    The vector of anti-HCV T cell receptor (TCR) is constructed for the engineering of T cell to target HCV. The T cells are genetically modified through transduction with a retroviral vector expressing HCV-specific T cell receptor. And the vector produc...